Mylan Announces Final Approval For Meloxicam Tablets

Main Category: Arthritis / Rheumatology
Article Date: 22 Jul 2006 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  


Current Article Ratings:

Patient / Public:4 stars

3.57 (7 votes)

Healthcare Prof:5 stars

5 (2 votes)

Article Opinions: 1 posts

Mylan Laboratories Inc. (NYSE: MYL) today announced that the U.S. Food and Drug Administration has granted final approval for Mylan Pharmaceuticals Inc.'s Abbreviated New Drug Application for Meloxicam Tablets, 7.5 mg and 15 mg.

Meloxicam Tablets are indicated for the relief of the signs and symptoms of osteoarthritis. They are the AB-rated generic equivalent of Boehringer Ingelheim's Mobic(R) Tablets, which had annual U.S. sales of approximately $1.1 billion for the 12 months ending March 31, 2006. This product will be shipped immediately.

Mylan Laboratories Inc. is a leading pharmaceutical company with three principal subsidiaries: Mylan Pharmaceuticals Inc., Mylan Technologies Inc. and UDL Laboratories Inc. Mylan develops, licenses, manufactures, markets and distributes an extensive line of generic and proprietary products. For more information about Mylan, please visit http://www.mylan.com/.

Mylan Laboratories Inc.
http://www.mylan.com/

Article adapted by Medical News Today from original press release.
Visit our arthritis / rheumatology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Christopher Backing. "Mylan Announces Final Approval For Meloxicam Tablets." Medical News Today. MediLexicon, Intl., 22 Jul. 2006. Web.
12 Feb. 2012. <http://www.medicalnewstoday.com/releases/47796.php>

APA
Christopher Backing. (2006, July 22). "Mylan Announces Final Approval For Meloxicam Tablets." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/47796.php.

Please note: If no author information is provided, the source is cited instead.




Arthritis / Rheumatology

What is Rheumatoid Arthritis?

Rheumatoid arthritis, sometimes referred to as rheumatoid disease, is a chronic (long lasting), progressive and disabling autoimmune disease that causes inflammation (swelling) and pain in the joints, the tissue around the joints, and other organs in... Read more...

Most Popular Articles





Follow Our Arthritis News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Arthritis / Rheumatology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »